The Scripps Research Institute has been granted over $3 million to develop molecular compounds to help fight disorders related to our body's "circadian rhythm," or internal clock.

Neuralstem, Inc. has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to kick off two safety trials testing a major depression treatment.

New research has examined the crucial steps involved that turn brand new blood cells into immune cells or red blood cells, and how disruptions to this process can lead to blood diseases like leukemia.

A naturally occurring antibiotic called defensin may be lacking in patients suffering from inflammatory bowel diseases like Crohn's and ulcerative colitis.

A "natural" alternative to cholesterol-lowering statin drugs, red yeast rice supplements vary widely in how much active ingredient they contain and some are even contaminated.

Resveratrol may help halt uncontrolled blood vessel growth in the eye, pointing the way to better therapies for conditions such as diabetic retinopathy and age-related macular degeneration (AMD).

Combining blood pressure medicines with common antibiotics is linked to shock in patients resulting from hypotension (low blood pressure), according to a new study.

Researchers are investigating whether lowering body temperature (hypothermia) can prevent or reduce brain damage in children deprived of oxygen after cardiac arrest.

Interferon-gamma, a protein primarily used for intercellular communication by the immune system, acts as a promoter for melanoma, the deadliest form of skin cancer.

Researchers at Ontario Cancer Institute (OCI) and collaborators at St Jude Children's Research Hospital are challenging the conventional view of how leukemia progresses.